| 0 | 💬 0 |
Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-02-17 | #vaccination #antibody #neutralization #immunotherapy #ebv |